Evidence map›Paper›PMID 38420439›Full record

ArticleHeliyon2024

A lightweight network for traffic sign recognition based on multi-scale feature and attention mechanism.

Wei Wei, Lili Zhang, Kang Yang, Jing Li, Ning Cui, Yucheng Han, Ning Zhang, Xudong Yang, Hongxin Tan, Kai Wang

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei WeiBeijing Institute of Petrochemical Technology, Beijing, 102617, China.
Lili ZhangBeijing Institute of Petrochemical Technology, Beijing, 102617, China.
Kang YangBeijing Institute of Petrochemical Technology, Beijing, 102617, China.
Jing LiBeijing Institute of Petrochemical Technology, Beijing, 102617, China.
Ning CuiBeijing Institute of Petrochemical Technology, Beijing, 102617, China.
Yucheng HanBeijing Institute of Petrochemical Technology, Beijing, 102617, China.
Ning ZhangBeijing Institute of Petrochemical Technology, Beijing, 102617, China.
Xudong YangBeijing Institute of Petrochemical Technology, Beijing, 102617, China.
Hongxin TanScience and Technology on Complex Aviation Systems Simulation Laboratory, Beijing, 100076, China.
Kai WangInstitute of National Defense Science and Technology Innovation, Academy of Military Sciences, Beijing, 100036, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traffic sign recognition is an important part of intelligent transportation system. It uses computer vision and traffic sign recognition technology to detect and recognize traffic signs on the road automatically. In this paper, we propose a lightweight model for traffic sign recognition based on convolutional neural networks called ConvNeSe. Firstly, the feature extraction module of the model is constructed using the Depthwise Separable Convolution and Inverted Residuals structures. The model extracts multi-scale features with strong representation ability by optimizing the structure of convolutional neural networks and fusing of features. Then, the model introduces Squeeze and Excitation Block (SE Block) to improve the attention to important features, which can capture key information of traffic sign images. Finally, the accuracy of the model in the German Traffic Sign Recognition Benchmark Database (GTSRB) is 99.85%. At the same time, the model has good robustness according to the results of ablation experiments.

Indexed as

Attention mechanismConvNeSeLightweightMulti-scale featureTraffic sign recognition

Identifiers

PMID38420439
PMCPMC10900943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.